Regeneron Pharmaceuticals, Inc.

Sembol: REGN

NASDAQ

957

USD

Bugünkü piyasa fiyatı

26.7418
F/K Oranı
0.3008
PEG Oranı
103.71B
MRK Kapağı
0.00%
DIV Verimi

Regeneron Pharmaceuticals, Inc. (REGN) Finansal Tablolar

Q: Nedir Regeneron Pharmaceuticals, Inc. (REGN) toplam varlıklar?

Regeneron Pharmaceuticals, Inc. (REGN) toplam varlıklar şeklindedir.

Download

Yıllık Üç Aylık

Doğrusal Günlük

Grafikte için dinamiklerde varsayılan sayıları görebilirsiniz Regeneron Pharmaceuticals, Inc. (REGN). Şirketin geliri 2585.271 M ortalamasını gösterir ki bu da 0.382 % gowth'dur. Tüm dönem için ortalama brüt kar 2297.251 M olup 0.359 % dir. Ortalama brüt kar oranı 0.827 %dır. Şirketin geçen yılki performansı için net gelir artışı -0.089 % olup -0.111 % %'ne eşittir. tüm şirket geçmişi için ortalama.,

Yıllık Üç Aylık

10Y 20Y 30Y 40Y

Bilanço

Regeneron Pharmaceuticals, Inc.'nın mali yörüngesine baktığımızda, ortalama bir varlık büyümesi gözlemliyoruz. Bu oran, ilginç bir şekilde, şirketin hem en yüksek hem de en düşük seviyelerini yansıtarak olarak gerçekleşiyor. Çeyrekten çeyreğe karşılaştırıldığında, bu rakam 0 olarak ayarlanmaktadır. Geçtiğimiz yıla bakıldığında toplam varlık değişiminin 0.132 olduğu görülür. Dönen varlıklar alanında, REGN raporlama para birimi cinsinden 19479.2 değerini gösterir. Bu varlıkların önemli bir kısmı, tam olarak 10844.8, nakit ve kısa vadeli yatırımlarda tutulmaktadır. Bu bölüm, geçen yılın verileriyle yan yana getirildiğinde -0.243% oranında bir değişim göstermektedir. Şirketin uzun vadeli yatırımları, odak noktası olmamakla birlikte, raporlama para biriminde 5396.5 seviyesindedir. Bu, şirketin stratejik değişimlerini yansıtan son raporlama dönemine göre -0.183%'lik bir farka işaret etmektedir. Şirketin borç profili, raporlama para biriminde 2702.9 uzun vadeli toplam borcu göstermektedir. Bu rakam, yıldan yıla 0.001%'lik bir değişimi ifade etmektedir. Toplam özkaynak ile gösterilen hissedar değeri, raporlama para biriminde 25973.1 olarak değerlenir. Bu açıdan yıldan yıla değişim 0.146%'dir. Şirketin mali tablolarına daha derinlemesine bakıldığında ek ayrıntılar ortaya çıkmaktadır. Net alacaklar 5667.3 değerinde, envanter 2580.5 değerinde ve varsa şerefiye 0 değerindedir. Varsa, toplam maddi olmayan duran varlıklar 1038.6 ile değerlenir.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994	1992	1990
balance-sheet.row.cash-and-short-term-investments	40205.6	10844.8	14334.1	12532.7	6722.6	6471.1	4564.9	2896.1	1902.9	1677.4	1360.6	1083.9	587.5	526.9	626.9	341.3	474.8	766.5	459.3	298.5	296	293.8	264.3	385.1	117.6	66.2	19.8	28.9	34.5	32.7	23.6	12.5	16.4	26.2	21.8
balance-sheet.row.short-term-investments	30784.1	8114.8	4636.4	2809.1	1393.3	1596.5	1342.2	596.8	503.5	236.1	251.8	158.4	77.8	43.3	136.8	134.3	227	267.5	221.4	114	194.7	175.5	184.2	137.7	86.6	42.5	0	0	0	0	0	0	0	0	0
balance-sheet.row.net-receivables	21595.3	5667.3	5328.7	6036.5	4114.7	2672.2	2243.2	1974.3	1611.6	1467.8	1017.4	891.8	693.1	103	93.1	65.6	35.2	18.3	7.5	36.5	43.1	15.5	4	3	13.8	0.6	5.7	6.6	4.3	2.7	1.7	1.7	1.1	1.4	0.2
balance-sheet.row.inventory	9865.6	2580.5	2401.9	1951.3	1916.6	1415.5	1151.2	726.1	399.4	238.6	128.9	70.4	28.6	13.6	-15.1	0	0	0	0	2.9	3.2	9	6.8	4	1.9	4.6	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-current-assets	1737	386.6	933	332.4	1164	959.3	243.3	225	130.5	163.5	120.7	140.8	176.2	810.5	15.1	18.6	11.5	13.1	3.2	3.4	1.6	1.9	1.8	2.2	0.8	1.6	67.4	64.1	46.2	13.8	26.7	77.6	67.2	79	0.4
balance-sheet.row.total-current-assets	73908.5	19479.2	22064.7	20520.5	12753.9	10558.8	7959.3	5596.6	3913.9	3383.8	2506.9	2252.2	1620.8	913.6	720.1	425.5	521.4	797.8	470	341.4	344	320.2	276.9	394.2	134.1	73	92.9	99.6	85	49.2	52	91.8	84.7	106.6	22.4
balance-sheet.row.property-plant-equipment-net	16300.6	4146.4	3763	3482.2	3221.6	2890.4	2575.8	2358.6	2083.4	1594.1	974.3	527	379.9	368	347.4	259.7	87.9	58.3	49.4	60.5	71.2	80.7	76.8	39.4	36.9	36.3	33	32.7	34.3	27.9	27.7	22.4	10.5	5.4	2.2
balance-sheet.row.goodwill	0	0	0	-6844.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	4067.5	1038.6	915.5	6.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.6	0.5
balance-sheet.row.goodwill-and-intangible-assets	4067.5	1038.6	915.5	-6838	-3135.6	-3256.8	-1755	-1486.5	-864.3	-632.2	-460.2	-621.8	-463.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.6	0.5
balance-sheet.row.long-term-investments	24562.5	5396.5	5406.4	6838	3135.6	3256.8	1755	1486.5	864.3	632.2	460.2	389.9	271.2	275.9	370.1	47.1	51.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	9795.6	2575.4	1723.7	876.9	858.9	824.2	828.7	506.3	825.3	461.9	316.1	231.9	192	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-non-current-assets	1635.9	444.1	-4658.8	555.2	328.9	531.8	370.7	302.8	150.8	169.3	74.5	171.8	79.8	-233.8	-348.1	8.9	9.7	80.1	65.8	21.6	57.9	78.6	37.8	61.8	37.2	27.7	31	36.1	18.3	16.7	14.5	3.4	2.7	0.4	0.3
balance-sheet.row.total-non-current-assets	56362.1	13601	7149.8	4914.3	4409.4	4246.4	3775.2	3167.7	3059.5	2225.4	1364.9	698.8	459.7	410	369.4	315.7	148.6	138.4	115.1	82.1	129.2	159.3	114.6	101.2	74.1	64	64	68.8	52.6	44.6	42.2	25.8	13.2	7.4	3
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	130270.6	33080.2	29214.5	25434.8	17163.3	14805.2	11734.5	8764.3	6973.5	5609.1	3871.8	2951	2080.5	1323.6	1089.4	741.2	670	936.3	585.1	423.5	473.1	479.6	391.6	495.4	208.3	137	156.9	168.4	137.6	93.8	94.2	117.6	97.9	114	25.4
balance-sheet.row.account-payables	2361.8	606.6	589.2	564	475.5	418.1	218.2	178.2	135	141	99.5	61.9	38.9	27.7	-48	18.6	6.3	8.1	21.5	23.3	18.9	18.9	30.3	14.8	9.4	6.6	5.6	4.7	4.4	6.3	5	10.3	2.5	1.6	0
balance-sheet.row.short-term-debt	0	0	720	719.7	1631.2	0	-90.8	468.8	127.3	452.6	350.2	0.9	1.4	1	0.7	0	-162.4	202.3	-21.5	-23.3	-18.9	13.8	0.1	0.4	0.6	1.4	1.1	1.8	3.6	3.5	3.1	1.6	1	0.4	0
balance-sheet.row.tax-payables	0	0	0.3	326.3	19.5	49.4	20.8	0.2	235.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.long-term-debt-total	10091	2702.9	2701.4	2699.7	2695.7	713.9	708.5	703.5	481.1	375.5	459.1	505.5	457.3	435.5	160	0	5.1	0	200	200	200	200	200	200.2	2.1	2.7	3.1	3.8	5.1	6	9.2	5.9	5.8	2.4	0
Deferred Revenue Non Current	554	126.7	69.8	515.3	635.5	1210.7	916.7	949.3	1062.4	818.2	250.3	231.2	259.2	248.6	340.6	137.9	162.4	0	123.5	69.1	56.4	68.8	5.5	6.9	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	770.4	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	9571.5	2357.9	1992.2	1725.3	122.4	781.1	772.1	0.3	486.7	13.6	96.4	152.4	27.5	73.3	53.7	30.4	29.9	28.8	21.5	23.3	18.9	0	0	0	3.7	5.3	2.7	4.2	4	3.1	9.8	1.2	1.1	1.3	0
balance-sheet.row.total-non-current-liabilities	14676.8	3683.7	2701.4	3215	3331.2	1924.6	1625.2	1652.8	1543.6	1193.7	709.4	736.7	716.5	435.5	500.6	250.9	167.5	192.3	323.5	269.1	256.4	269	205.5	207	12.4	14.2	16.3	18.8	18.7	13	9.2	6.1	6.1	4.5	11.4
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	2880	720	720	719.7	717.2	713.9	708.5	703.5	481.1	364.7	312.3	185.2	160.8	160.5	160	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	28384.1	7107.1	6550.5	6666	6138	3715.5	2977.2	2620.2	2524.2	1954.3	1329.5	998.9	835.1	837.9	561.6	344.4	251.2	476	368.5	309.5	290.6	341.9	245.6	229	26.1	27.5	25.7	29.5	30.7	25.9	27.1	19.2	10.7	7.8	13.2
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.retained-earnings	106436.2	27260.3	23306.7	18968.3	10893	7379.8	5254.3	2946.7	1748.2	852.7	255.4	-92.7	-517.1	-1267.3	-1045.6	-941.1	-875.9	-793.2	-687.6	-585.3	-489.8	-531.5	-424.1	-299.7	-223.5	-200.3	-177.2	-168.6	-157	-124.6	-101.1	-70.4	-30.6	-11.4	-7
balance-sheet.row.accumulated-other-comprehensive-income-loss	-532.6	-80.9	-238.8	-26.2	29.3	21.1	-12.3	0.6	-12.8	8.6	52.3	-1.2	-1.2	-1.9	-2.5	1	-0.1	0.2	-0.2	-0.8	-3.1	-4	-3.2	-1.6	-0.8	-0.5	-26.6	-23.6	-5.9	-5.9	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	-4017.5	-1206.4	-404	-173.4	102.9	3688.7	3515.2	3196.6	2713.8	2793.5	2234.6	2045.9	1763.5	1754.8	1575.8	1336.7	1294.8	1253.2	904.4	700	675.4	673.1	573.2	567.6	406.4	310.3	335	331.1	269.8	198.4	168.2	168.8	117.8	117.6	19.2
balance-sheet.row.total-stockholders-equity	101886.5	25973.1	22664	18768.8	11025.3	11089.7	8757.3	6144.1	4449.2	3654.8	2542.3	1952.1	1245.4	485.7	527.8	396.8	418.9	460.3	216.6	114	182.5	137.6	146	266.4	182.1	109.5	131.2	138.9	106.9	67.9	67.1	98.4	87.2	106.2	12.2
balance-sheet.row.total-liabilities-and-stockholders-equity	130270.6	33080.2	29214.5	25434.8	17163.3	14805.2	11734.5	8764.3	6973.5	5609.1	3871.8	2951	2080.5	1323.6	1089.4	741.2	670	936.3	585.1	423.5	473.1	479.6	391.6	495.4	208.3	137	156.9	168.4	137.6	93.8	94.2	117.6	97.9	114	25.4
balance-sheet.row.minority-interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-equity	101886.5	25973.1	22664	18768.8	11025.3	11089.7	8757.3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	130270.6	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	45970.9	13511.3	10042.8	9647.1	4528.9	4853.3	3097.2	2083.3	1367.7	868.3	711.9	548.3	349	319.2	506.8	181.3	278	267.5	221.4	114	194.7	175.5	184.2	137.7	86.6	42.5	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-debt	10811	2702.9	2701.4	2699.7	2695.7	713.9	708.5	703.5	481.1	375.5	459.1	505.5	457.3	435.5	160	0	5.1	202.3	200	200	200	213.8	200.2	200.6	2.7	4.1	4.2	5.6	8.7	9.5	12.3	7.5	6.8	2.8	0
balance-sheet.row.net-debt	1389.5	-27.1	-404.5	-185.9	502	-903.9	-759.2	-109.3	-54.1	-433.6	-189.7	-30.1	227.1	-48.1	47.5	-98.1	-242.7	-296.6	-37.9	15.5	98.8	95.5	120.1	-46.8	-28.3	-19.6	-15.6	-23.3	-25.8	-23.2	-11.3	-5	-9.6	-23.4	-21.8

Nakit Akış Tablosu

Regeneron Pharmaceuticals, Inc.'nın mali durumu son dönemde serbest nakit akışında kayda değer bir değişim göstererek -0.171 şeklinde bir değişim sergilemiştir. Şirket kısa süre önce 1145.5 ihraç ederek sermayesini artırmış ve bir önceki yıla kıyasla 0.000 oranında bir farka işaret etmiştir. Şirketin yatırım faaliyetleri, raporlama para birimi cinsinden -3185100000.000 tutarında net nakit kullanımıyla sonuçlanmıştır. Bu, bir önceki yıla göre -0.158 değişimidir. Aynı dönemde şirket, şirketin yatırım ve geri ödeme stratejilerini anlamada önemli olan 421, 0 ve 0 'i kaydetti. Şirketin finansman faaliyetleri 0.000 net nakit kullanımına yol açmış ve bir önceki yıla göre 0.000 farkı oluşmuştur. Ayrıca, şirket hissedarlarına temettü ödemeleri için 0 ayırmıştır. Aynı zamanda, -700.6 olarak adlandırılan ve bu dönemde nakit akışını önemli ölçüde etkileyen başka finansal manevralar da yapmıştır. Bu bileşenler birlikte ele alındığında, şirketin finansal durumu ve nakit akışı yönetimine yönelik stratejik yaklaşımı hakkında kapsamlı bir resim çizmektedir.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994	1992
cash-flows.row.net-income	3857.8	3953.6	4338.4	8075.3	3513.2	2115.8	2444.4	1198.5	895.5	636.1	348.1	424.4	750.3	-221.8	-104.5	-67.8	-82.7	-105.6	-102.3	-95.4	41.7	-107.5	-124.4	-76.2	-23.2	-23.1	-8.6	-11.6	-32.4	-23.5	-30.7	-39.9	-19.1	-4.5
cash-flows.row.depreciation-and-amortization	435.6	421	341.4	286.2	235.9	210.3	148.2	145.5	104.7	74.9	52.7	41.2	36.9	31.1	19.7	14.2	11.3	11.5	14.6	15.5	15.4	12.9	8.5	6.1	4.4	3.4	3	4.4	6.1	5.9	4.2	3.1	2	0.8
cash-flows.row.deferred-income-tax	-811.7	-837.8	-746.4	-147.1	75.6	-130.6	-140	318.8	-360.1	-121.6	-66.6	63.6	-340.2	0	0	-0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	876.4	885	725	601.7	432	464.3	427.4	507.3	559.9	459	307.2	198.4	94.2	56.1	39.9	31.3	32.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	105.5	-94.1	-243.3	-1916.5	-1503.6	-200.5	-697	-926.5	228.2	229.8	20.2	-190.7	-672.8	-17.5	140.9	-49.5	-52.4	87.5	93	27.8	-58.7	84.3	3.6	11	-15.3	1.2	-7.4	-2.6	-8.5	-14.8	-3	3.1	1.5	-0.6
cash-flows.row.account-receivables	-102.1	-338.8	707.8	-1927.4	-1356.1	-473.1	-268.9	-362.7	-143.8	-491.4	-62.4	-198.7	-590.1	-21.1	-27.5	-30.4	-16.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	-380.7	-271.7	-696.5	-494.3	-529.4	-335.5	-387.9	-314.2	-149.8	-111.8	-60.9	-48	-52.6	0	0	-4.6	0	0	3.6	1.3	6.9	-1	-1.7	-0.9	4	-4	0	0	0	0	0	0	0	0
cash-flows.row.account-payables	478.9	598.6	-138.4	866.1	118.9	444.5	210	-23.2	254	303.7	162.2	136.7	11	0	0	13	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	109.4	-82.2	-116.2	-360.9	263	163.6	-250.2	-226.4	267.8	529.4	-18.7	-80.7	-41.1	3.7	168.5	-27.5	-35.5	87.5	89.4	26.5	-65.7	85.4	5.3	12	-19.3	5.2	-7.4	-2.6	-8.5	-14.8	0	0	0	0
cash-flows.row.other-non-cash-items	332.1	266.3	599.8	181.7	-135	-29.3	12.1	-36.9	485.7	619.8	361.6	133.7	-861.8	10.4	0.3	-0.4	2.2	34	17.9	21.9	-15.2	4.1	1.8	1.8	6.1	4.7	2.8	3.7	14.5	14.2	9	3.6	-1.6	-2.5
cash-flows.row.net-cash-provided-by-operating-activities	4738.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-764.3	-926.4	-590.1	-551.9	-614.6	-429.6	-383.1	-272.6	-511.9	-677.9	-333	-156.3	-49.3	-57.2	-99.7	-97.3	-34.9	-18.4	-2.8	-5	-6.2	-29.7	-34.4	-8.2	-6.5	-5.7	-3	-2.1	-8.6	-3.3	-6.9	-10.2	-2.1	-1
cash-flows.row.acquisitions-net	330	-54.9	-230.3	551.9	614.6	429.6	1069.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.purchases-of-investments	-15554.1	-11646	-7487.9	-7048.1	-3241	-3202.4	-1845.5	-1277.1	-809.4	-557.1	-564.2	-577.3	-470.4	-240.4	-612.2	-200	-581.1	-594.4	-456.9	-103	-276.3	-287.5	-240	-191.4	-104.9	-60.1	-88	-112.6	-74.6	-28.1	-22.5	-77.3	-71.6	-137.2
cash-flows.row.sales-maturities-of-investments	11781.6	9442.2	5550.5	2215.3	3785	1604.2	775.6	544.6	274.5	327.4	476.4	378.1	439.2	426.4	276.6	297.4	646.9	527.2	306.2	223.4	277.9	253.3	215.8	124.2	53.7	83.2	93.5	75.9	38.9	38.8	61.3	68.5	82.8	61.8
cash-flows.row.other-investing-activites	-1793.9	0	-1026.8	-551.9	-614.6	-429.6	-1079.9	-732.6	-534.9	-229.7	-87.8	-199.1	-31.7	-0.3	1.1	0.1	-0.1	0	-1.6	0	0	0	0	0	0	0.1	-0.1	-0.1	0	0	0	-4.6	-0.9	-1.2
cash-flows.row.net-cash-used-for-investing-activites	-4636.5	-3185.1	-3784.6	-5384.7	-70.6	-2027.8	-1463	-1005.2	-1046.9	-907.6	-420.8	-355.5	-81.1	128.5	-434.2	0.1	30.8	-85.7	-155.1	115.5	-4.6	-63.8	-58.5	-75.4	-57.7	17.5	2.4	-38.9	-44.3	7.4	31.9	-23.6	8.2	-77.6
cash-flows.row.debt-repayment	0	0	0	0	-1500	0	0	-19.9	-40.6	-166.5	-221.7	-2	-2.2	-1.7	-1	0	-200.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-issued	1342.4	1145.5	1519.5	1672.3	2575.2	211.8	114.5	240.2	126.7	206.4	126	57.4	63.5	18.5	196.8	8.6	7.9	319.4	185	4.1	1.5	94.7	2.1	158.5	94.4	1.4	0.5	43.4	70	23.2	0	51.1	0	91.6
cash-flows.row.common-stock-repurchased	-2419.2	-2935.6	-2528.5	-2678.1	-6527.6	-463.9	-191.6	-301.7	-143.2	-160.5	-267.6	-195.1	-163.3	0	0	0	0	0	0	0	-0.9	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	0	0	0	0	0	0	0	-358.7	-500.2	-547.5	-294.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-financing-activites	-947.3	-700.6	-445.7	-1032.7	3481.9	-188	0	415.7	-143.2	405.3	448.6	216.9	4.3	367.4	47.5	22.8	0	0	0.4	0	3.8	13.5	-0.4	190.6	-1.5	-1.1	-1.9	-4	-3.7	-3.3	-0.2	-1.3	-0.8	-0.1
cash-flows.row.net-cash-used-provided-by-financing-activities	-1420.5	-1790.1	-1009	-1005.8	-1970.5	-252.1	-77.1	-24.4	-700.4	-262.8	-209.3	77.1	-97.6	384.2	243.3	31.4	-192.9	319.4	185.4	4.1	4.4	108.2	1.7	349.1	92.9	0.3	-1.4	39.4	66.3	19.9	-0.2	49.8	-0.8	91.5
cash-flows.row.effect-of-forex-changes-on-cash	3764.4	-0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-0.1	0	0	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	-1319	-381.6	221.3	690.8	577	150.1	655	277.5	-273.9	160.4	113.1	305.3	-253.3	371	-94.5	-40.7	-251.1	261	53.4	89.3	-17.1	38.2	-167.3	216.4	7.3	3.9	-9.2	-5.6	1.7	9.1	11.2	-3.9	-9.8	7.1
cash-flows.row.cash-at-end-of-period	9449.7	2737.8	3119.4	2898.1	2207.3	1630.3	1480.2	812.7	535.2	809.1	648.7	535.6	230.3	483.6	112.6	207.1	247.8	498.9	237.9	184.5	101.2	118.3	80.1	247.4	31	23.7	19.7	28.9	34.4	32.7	23.7	12.5	16.4	26.3
cash-flows.row.cash-at-beginning-of-period	10768.7	3119.4	2898.1	2207.3	1630.3	1480.2	825.2	535.2	809.1	648.7	535.6	230.3	483.6	112.6	207.1	247.8	498.9	237.9	184.5	95.2	118.3	80.1	247.4	31	23.7	19.8	28.9	34.5	32.7	23.6	12.5	16.4	26.2	19.2
cash-flows.row.operating-cash-flow	4738.9	4594	5014.9	7081.3	2618.1	2430	2195.1	1307.1	1485.9	1330.8	752.4	588.6	-74.6	-141.7	96.3	-72.2	-89.1	27.4	23.1	-30.3	-16.9	-6.1	-110.5	-57.3	-27.9	-13.8	-10.2	-6.1	-20.3	-18.2	-20.5	-30.1	-17.2	-6.8
cash-flows.row.capital-expenditure	-764.3	-926.4	-590.1	-551.9	-614.6	-429.6	-383.1	-272.6	-511.9	-677.9	-333	-156.3	-49.3	-57.2	-99.7	-97.3	-34.9	-18.4	-2.8	-5	-6.2	-29.7	-34.4	-8.2	-6.5	-5.7	-3	-2.1	-8.6	-3.3	-6.9	-10.2	-2.1	-1
cash-flows.row.free-cash-flow	3974.6	3667.6	4424.8	6529.4	2003.5	2000.4	1812	1034.5	974	652.8	419.4	432.3	-124	-198.9	-3.3	-169.5	-123.9	8.9	20.3	-35.3	-23.1	-35.8	-144.9	-65.5	-34.4	-19.5	-13.2	-8.2	-28.9	-21.5	-27.4	-40.3	-19.3	-7.8

Gelir Tablosu Satırı

Regeneron Pharmaceuticals, Inc.'nın geliri bir önceki döneme göre 0.078% oranında bir değişim gösterdi. Şirketin REGN brüt kârı 11301.4 olarak raporlanmıştır. Şirketin işletme giderleri 7068.2 olup, geçen yıla göre 25.802% değişim göstermiştir. Amortisman ve itfa giderleri 421, yani -0.031% son hesap dönemine göre değişimdir. İşletme giderleri 7068.2 olarak raporlanmıştır ve yıldan yıla 25.802% değişim göstermektedir. Satış ve pazarlama giderleri 0, bir önceki yıla göre 0.000% değişimdir. Son rakamlara göre FAVÖK 0 olup, yıldan yıla -0.146% büyümeyi temsil etmektedir. Faaliyet geliri 4047.1 olup, bir önceki yıla göre -0.146% değişim göstermektedir. Net gelirdeki değişim -0.089%'dir. Geçen yılın net geliri 3953.6 idi.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994	1992	1990
income-statement-row.row.total-revenue	13100.1	13117.2	12172.9	16071.7	8497.1	7863.4	6710.8	5872.2	4860.4	4103.7	2819.6	2104.7	1378.5	445.8	459.1	379.3	238.5	125	63.4	66.2	174	57.5	22	22	59.3	34.5	38.2	33.1	24.1	27.4	23.2	10.6	11.5	7.3	5
income-statement-row.row.cost-of-revenue	1681.7	1815.8	1560.4	2437.5	1119.9	782.2	434.1	397.1	299.7	392.7	205	155.4	84.5	4.2	2.1	1.7	0.9	0	8.1	9.6	15.2	6.7	6.5	6.5	15.6	3.6	5	2.6	1.1	0	0	0	0	12.8	6.3
income-statement-row.row.gross-profit	11418.4	11301.4	10612.5	13634.2	7377.2	7081.2	6276.7	5475.2	4560.7	3711	2614.5	1949.4	1294	441.6	457	377.6	237.5	125	55.3	56.6	158.8	50.8	15.5	15.5	43.7	30.9	33.2	30.5	23	27.4	23.2	10.6	11.5	-5.5	-1.3
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	4472.1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	53.3	-20	-89.9	-45.6	-280.4	219.3	19.1	-1.1	-0.9	0	0	0	0	0	0	0	0	0	0	-248.8	0	0	0	0	4.4	3.4	3	4.4	6.1	5.9	4.2	3.1	2	0.8	0.3
income-statement-row.row.operating-expenses	7205.5	7068.2	5618.5	4687.4	3800.6	4871.4	3742.3	3395.6	3230	2459.1	1776.1	1189.4	836.3	646.8	554.5	451.7	327.4	239.5	163	-67.8	153.2	150.8	137.5	101.1	69	54.7	45.8	38	40.3	35	52.4	49.4	29.8	4.1	2
income-statement-row.row.cost-and-expenses	8887.2	8884	7178.9	7124.9	4920.5	5653.6	4176.4	3792.6	3529.7	2851.8	1981.1	1344.7	920.8	651	556.5	453.4	328.3	239.5	171.1	-58.2	168.4	157.5	143.9	107.7	84.6	58.3	50.8	40.6	41.4	35	52.4	49.4	29.8	16.9	8.3
income-statement-row.row.interest-income	562.2	495.9	160.1	45.8	18.5	30.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.interest-expense	35.5	73	59.4	57.3	56.9	30.2	28.2	25.1	7.2	14.2	37.4	46.4	45.3	21.3	9.1	2.3	7.8	-20.9	-16.5	-41	-48.2	-4.5	-9.4	-12.2	4.6	-1	-4.4	3.4	14.3	14.7	0	0	0	-5.2	0
income-statement-row.row.selling-and-marketing-expenses	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	41.6	-456.8	119.9	379	233.8	219.3	19.1	-1.1	-0.9	-12.6	-25.3	-0.2	2	3.5	2.1	4.5	17.2	20.9	16.5	41	48.2	4.5	9.4	12.2	-4.6	1	4.4	-3.4	-14.3	-14.7	0	0	0	5.2	0
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	53.3	-20	-89.9	-45.6	-280.4	219.3	19.1	-1.1	-0.9	0	0	0	0	0	0	0	0	0	0	-248.8	0	0	0	0	4.4	3.4	3	4.4	6.1	5.9	4.2	3.1	2	0.8	0.3
income-statement-row.row.total-operating-expenses	41.6	-456.8	119.9	379	233.8	219.3	19.1	-1.1	-0.9	-12.6	-25.3	-0.2	2	3.5	2.1	4.5	17.2	20.9	16.5	41	48.2	4.5	9.4	12.2	-4.6	1	4.4	-3.4	-14.3	-14.7	0	0	0	5.2	0
income-statement-row.row.interest-expense	35.5	73	59.4	57.3	56.9	30.2	28.2	25.1	7.2	14.2	37.4	46.4	45.3	21.3	9.1	2.3	7.8	-20.9	-16.5	-41	-48.2	-4.5	-9.4	-12.2	4.6	-1	-4.4	3.4	14.3	14.7	0	0	0	-5.2	0
income-statement-row.row.depreciation-and-amortization	435.6	421	434.4	436.3	290.7	210.3	148.2	145.5	104.7	74.9	52.7	41.2	36.9	31.1	19.7	14.2	11.3	11.5	14.6	15.5	15.4	12.9	8.5	6.1	4.4	3.4	3	4.4	6.1	5.9	4.2	3.1	2	0.8	0.3
income-statement-row.row.ebitda-caps	4452.2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	3858.9	4047.1	4738.9	8946.8	3576.6	2209.8	2534.4	2079.6	1330.7	1251.9	838.4	760	457.7	-205.2	-97.5	-74.1	-89.8	-114.5	-107.7	124.4	5.6	-100	-122	-85.7	-25.3	-23.8	-12.6	-7.5	-17.3	-7.6	-29.2	-38.8	-18.3	-9.6	-3.3
income-statement-row.row.income-before-tax	4042	4199.3	4858.8	9325.8	3810.4	2429.1	2553.5	2078.5	1329.8	1225.1	775.7	713.4	414.4	-222.9	-104.5	-72	-80.4	-93.6	-91.1	124.4	53.9	-95.5	-112.5	-73.5	-29.9	-22.8	-8.2	-7.5	-17.3	-7.6	0	0	0	-4.4	0
income-statement-row.row.income-tax-expense	184.2	245.7	520.4	1250.5	297.2	313.3	109.1	880	434.3	589	427.7	289	-335.8	-1.1	-2.1	-4.1	2.4	-29.8	-21.9	178.8	-84.3	3	-7	-21.7	2.5	-1.7	-8.4	7.5	29.4	30.6	1.5	1.1	0.8	-10.3	0
income-statement-row.row.net-income	3857.8	3953.6	4338.4	8075.3	3513.2	2115.8	2444.4	1198.5	895.5	636.1	348.1	424.4	750.3	-221.8	-104.5	-67.8	-82.7	-105.6	-102.3	-95.4	41.7	-107.5	-124.4	-76.2	-23.2	-23.1	-8.6	-11.6	-32.4	-23.5	-30.7	-39.9	-19.1	-4.5	-3.3